| HALL A | |||
| 13:00 - 13:30 | SESSION: Beyond Alpha-Blockers: Personalized Pharmacologic Management of LUTS/BPH | ||
| 13:00 - 13:08 | Monotherapy | ||
| 13:09 - 13:17 | Combination Therapy | ||
| 13:18 - 13:25 | Phytotherapy | ||
| 13:26 - 13:30 | Discussion | ||
| 13:30 - 14:30 | SESSION: Localized Prostate Cancer Prostate Biopsy in 2026: Evidence Behind the Needle, Current Strategies and Future Perspectives |
||
| 13:30 - 13:40 | Current Status of Screening for Clinically Significant Prostate Cancer | ||
| 13:40 - 13:50 | Is Systematic Biopsy Becoming Obsolete? Evidence and Modern Approaches | ||
| 13:50 - 14:00 | High-Resolution Approaches in Prostate Cancer: The Micro-Ultrasound Advantage | ||
| Limits of active surveillance in prostate cancer and the effect of imaging on active surveillance | |||
| 14:00 - 14:04 | Case presentation | ||
| 14:05 - 14:10 | Pathologist perspective | ||
| 14:10 - 14:15 | Radiologist perspective | ||
| 14:15 - 14:20 | Nuclear Medicine perspective | ||
| 14:20 - 14:30 | Discussion | ||
| 14:30 - 14:40 | Systemic Therapy in Localized Prostate Cancer: Necessary or Debatable | ||
| 14:40 - 14:55 | Coffee Break  |
||
| 14:55 - 15:45 | Game Changing Session | ||
| 14:55 - 15:00 | AMPLITUDE | ||
| 15:00 - 15:05 | PSMAddition | ||
| 15:05 - 15:10 | CAPItello-281 | ||
| 15:10 - 15:15 | EMBARK | ||
| 15:15 - 15:20 | ARASAFE | ||
| 15:20 - 15:25 | PACE B+C | ||
| 15:25 - 15:30 | CREST | ||
| 15:30 - 15:35 | POTOMAC | ||
| 15:35 - 15:45 | Expert Q&A: Closing Remarks | ||
| 15:45 - 16:10 | SESSION: Minimal invasive, Maximally Targeted: Focal Therapy in GU malignancies | ||
| 15:45 - 15:55 | Prostate Cancer | ||
| 15:55 - 16:05 | Kidney Cancer | ||
| 16:05 - 16:10 | Discussion | ||
| 16:10 - 17:00 | SESSION: Locally Advanced Prostate Cancer Locally Advanced Prostate Cancer: Blade or Beam |
||
| 16:10 - 16:14 | Case presentation | ||
| 16:15 - 16:20 | Radiation Oncologist perspective | ||
| 16:20 - 16:25 | Urologist perspective | ||
| 16:25 - 16:30 | Medical Oncologist perspective | ||
| 16:30 - 16:40 | Discussion | ||
| Managing Biochemical Recurrence after Radical Prostatectomy: What is the optimal approach? | |||
| 16:40 - 16:47 | Radiotherapy ± ADT | ||
| 16:48 - 16:55 | Systemic Treatment Alone | ||
| 16:55 - 17:00 | Discussion | ||
| 17:00 - 17:10 | Coffee Break |
||
| 17:10 - 18:15 | SESSION: Advanced Urogenital Cancer Oligometastatic Urogenital Cancers: Limited Disease - Unlimited Debate |
||
| 17:10 - 17:17 | Prostate | ||
| 17:18 - 17:25 | Bladder | ||
| 17:25 - 17:32 | Kidney | ||
| 17:32 - 17:35 | Discussion | ||
| Targeted and Systemic Therapies: Metastatic Prostate Cancer Session | |||
| 17:35 - 17:45 | Directing Therapy to Metastases: Current Clinical Approaches | ||
| 17:45 - 17:55 | Double vs triple therapy in de novo mHSPCa | ||
| 17:55 - 18:05 | Hormone-Resistant Prostate Cancer: Treatment Strategies and Challenges | ||
| 18:05 - 18:15 | Discussion | ||
| HALL A | |||
| 08:30 - 09:30 | SESSION: Overlooked in Uro-Oncology: Critical Details Missing in Clinical Practice | ||
| 08:30 - 08:37 | Green surgery | ||
| 08:38 - 08:46 | From Guidelines to Practice: Applying Genetics and Genomics in urooncology | ||
| 08:47 - 08:53 | Burn-out in urooncology | ||
| 08:54 - 09:00 | Systemic Therapy Blind Spots: Navigating Underrecognized Challenges in Clinical Practice | ||
| Forensic Approaches in Urology: Legal Challenges in Clinical Practice | |||
| 09:00 - 09:15 | Case 1 | ||
| 09:15 - 09:30 | Case 2 | ||
| 09:30 - 09:45 | Coffee Break |
||
| 09:45 - 10:15 | OPENING CEREMONY | ||
| 09:45 - 10:00 | Congress Chairman: | ||
| 10:00 - 10:05 | Turkish Urology Association Chairman: | ||
| 10:05 - 10:10 | Honorary President of Turkish Urology Association: | ||
| 10:10 - 10:15 | Eurasian Uro-oncological Association Chairman: | ||
| 10:15 - 10:45 | Satellite Symposium | ||
| 10:45 - 11:20 | SESSION: Neoadjuvant Therapy on the Road to Uro-Oncologic Surgery: New Paradigms in Multidisciplinary Management | ||
| 10:45 - 10:55 | Prostate Cancer | ||
| 10:55 - 11:05 | Bladder Cancer/UTUC | ||
| 11:05 - 11:15 | RCC | ||
| 11:15 - 11:20 | Discussion | ||
| 11:20 - 11:55 | SESSION: Bridging Surgery And Systemic Therapy: Adjuvant Treatments | ||
| 11:20 - 11:30 | Prostate Cancer | ||
| 11:30 - 11:40 | Bladder Cancer/UTUC | ||
| 11:40 - 11:50 | RCC | ||
| 11:50 - 11:55 | Discussion | ||
| 11:55 - 12:30 | SESSION: Multidisciplinary Perspectives: Decision-Making in a Challenging Prostate Cancer Case | ||
| 11:55 - 11:58 | Case presentation | ||
| 11:58 - 12:05 | Urologist Perspective | ||
| 12:05 - 12:15 | Radiation Oncologist perspective | ||
| 12:15 - 12:25 | Medical Oncologist Perspective | ||
| 12:25 - 12:30 | Discussion | ||
| 12:30 - 13:30 | Lunch Break  |
||
| 13:30 - 14:15 | SESSION: Bladder Cancer: Current Evidence-Based Approaches in Diagnosis and Treatment | ||
| 13:30 - 13:38 | Beyond Cytology in Bladder Cancer: The Latest Advances in Biomarkers | ||
| 13:38 - 13:46 | Multiparametric MRI for Bladder Cancer Management: From Diagnosis to Response Evaluation | ||
| 13:46 - 13:54 | A Shift in TURBT: The Rise of En-Bloc Techniques | ||
| 13:54 - 14:02 | Selecting a BCG Strain: Evaluating Safety, Efficacy, and Tolerability | ||
| 14:02 - 14:10 | New horizons in BCG unresponsive disease | ||
| 14:10 - 14:15 | Discussion | ||
| 14:15 - 15:00 | SESSION: Bladder Cancer: High-Grade NMIBC: Management Strategies for Challenging Cases | ||
| 14:15 - 14:20 | Case presentation | ||
| 14:20 - 14:27 | Pathologist perspective: Are Molecular Subtypes and Variant Histologies Ready for Routine Clinical Decision-Making | ||
| 14:28 - 14:35 | Urologist perspective: Current Treatment Approaches | ||
| 14:36 - 14:43 | Urologist perspective: De-intensification | ||
| 14:44 - 14:52 | BCG + Immunotherapy in High-Risk BCG-Naive NMIBC: The Next Standard of Care? | ||
| 14:53 - 15:00 | Discussion | ||
| 15:00 - 15:30 | Satellite Symposium | ||
| 15:30 - 15:45 | Coffee Break |
||
| 15:45 - 16:45 | Semi-live Video Session | ||
| 15:45 - 15:55 | New Standards in Prostate Cancer Surgery with Robotics | ||
| 15:55 - 16:05 | Robotic Revolution in Bladder Cancer: Radical Cystectomy Experience | ||
| 16:05 - 16:15 | Key Steps and Pearls in Partial Nephrectomy | ||
| 16:15 - 16:25 | The Magneto Device: How Is This Innovation Transforming Endourology | ||
| 16:25 - 16:35 | Robotic Solution in BPH Treatment: Prostate Adenomectomy | ||
| 16:35 - 16:45 | Partial Adrenalectomy Experience: Technical Tips and Clinical Recommendations | ||
| 16:45 - 17:15 | Satellite Symposium | ||
| 17:15 - 17:45 | SESSION: Lymphadenectomy in Urooncology: Limits, Indications, and Controversies | ||
| 17:15 - 17:22 | Prostate Cancer | ||
| 17:23 - 17:33 | Urothelial Cancers (Bladder+UTUC) | ||
| 17:33 - 17:40 | Testicular cancer | ||
| 17:40 - 17:45 | Discussion | ||
| 17:45 - 18:15 | SESSION: Robotics Theater | ||
| 17:45 - 17:55 | Robotic Urology's New Weapons: The Power of Evolving Instrumentation | ||
| 17:55 - 18:05 | Anatomically Refined RaRP: Fascia-Sparing Strategies and Emerging Techniques | ||
| 18:05 - 18:15 | Video Masterclass: Minimizing and Managing Risks in Robotic Partial Nephrectomy | ||
| HALL B | |||
| 08:30 - 09:45 | SESSION: MR+Bx and Focal Treatment Course | ||
| 08:30 - 08:40 | Transperineal Approach: The New Gold Standard? | ||
| 08:40 - 08:50 | Fusion Biopsy: Which Technique to Choose? Cognitive, Software-Based, or In-Bore | ||
| 08:50 - 09:00 | Limits of Targeted Biopsy: Do We Still Need Combination Approaches? | ||
| 09:00 - 09:10 | Critical Pre-biopsy Steps: Sterilization and Surgical Field Preparation | ||
| 09:10 - 09:20 | MRI Software and Ultrasound Systems: Current Advances in Fusion Technology | ||
| 09:20 - 09:30 | Micro-Ultrasound–Guided Fusion Prostate Biopsy: A Next-Generation Diagnostic Tool | ||
| 09:30 - 09:45 | Patient Counseling, Anesthesia Selection, and Complication Management in Prostate Biopsy | ||
| 09:45 - 10:00 | Expert Q&A Session: Closing Remarks and Final Assessment | ||
| 10:00 - 10:15 | Coffee Break |
||
| 10:15 - 11:45 | Balkan Countries Session | ||
| 11:45 - 12:30 | Oral Presentation Session 1 | ||
| 12:30 - 13:30 | Lunch Break |
||
| 13:30 - 14:40 | SESSION: Penile Rehabilitation after Uro-oncology Surgeries: Masterclass Course | ||
| 13:30 - 13:40 | Role of PDE5 Inhibitors After RP: Evidence-Based Patient Selection and Timing | ||
| 13:40 - 13:50 | Regenerative Approaches to ED: The Emerging Role of Li-ESWT | ||
| 13:50 - 14:00 | Restoring Erectile Function Through Stem Cell Treatment | ||
| 14:00 - 14:15 | Penile Prosthesis Implantation: Surgical Nuances of Penoscrotal and Infrapubic Approaches | ||
| 14:15 - 14:25 | Understanding Penile Size Changes After RP: What Clinicians Should Know | ||
| 14:25 - 14:40 | Expert Q&A Session: Closing Remarks and Final Assessment | ||
| 14:40 - 15:00 | Coffee Break |
||
| 15:00 - 17:00 | Oral Presentation Session 2 | ||
| HALL A | |||
| 08:20 - 09:00 | SESSION: Most Debating Issues in Urooncology | ||
| Radical Cystectomy without TUR | |||
| 08:20 - 08:25 | Yes | ||
| 08:25 - 08:30 | No | ||
| MIBC | |||
| 08:30 - 08:40 | RC | ||
| 08:40 - 08:45 | TMT | ||
| 74-Year-Old with a 3 cm Renal Tumor | |||
| 08:45 - 08:50 | Ablation | ||
| 08:50 - 08:55 | PN | ||
| 08:55 - 09:00 | SBRT | ||
| 09:00 - 10:05 | SESSION: Muscle-Invasive Bladder Cancer Surgery Tips & Tricks Session | ||
| 09:00 - 09:08 | Radical Cystectomy in Men | ||
| 09:09 - 09:17 | Radical Cystectomy in Women | ||
| Urinary diversion | |||
| 09:18 - 09:26 | Neobladder | ||
| 09:27 - 09:35 | İleal conduit | ||
| 09:35 - 09:45 | Management of Early and Late Complications in Radical Cystectomy | ||
| 09:45 - 09:55 | Nephron-Sparing Strategies in Upper Tract Urothelial Carcinoma: Timing and Criteria | ||
| 09:55 - 10:05 | Radical Nephroureterectomy: Surgical Approaches and Key Technical Pearls | ||
| 10:05 - 10:15 | Coffee Break |
||
| 10:15 - 10:45 | SESSION: Metastatic Bladder Cancer: Case-Based Clinical Discussions Team-Based Decision-Making in Oligometastatic Bladder Cancer: Challenging Case Discussion |
||
| 10:15 - 10:19 | Case Presentation | ||
| 10:20 - 10:28 | Medical Oncologist Perspective | ||
| 10:29 - 10:37 | Radiation Oncologist Perspective | ||
| 10:38 - 10:45 | Urologist Perspective | ||
| 10:45 - 11:15 | Satellite Symposium: First-Line Therapies in Metastatic Bladder Cancer | ||
| 11:15 - 12:30 | SESSION: Kidney Cancer Session: Evidence-Based Strategies and Latest Guidelines | ||
| 11:15 - 11:25 | Updates in Kidney Cancer: What’s New in the WHO Classification | ||
| Diagnosis precision in RCC | |||
| 11:25 - 11:29 | Case presentation | ||
| 11:30 - 11:37 | Radiologist perspective | ||
| 11:38 - 11:45 | Pathologist perspective | ||
| 11:45 - 11:52 | Nuclear Medicine perspective | ||
| 11:53 - 12:03 | Critical Technical Pearls in Nephron-Sparing Surgery | ||
| Vena Cava Thrombus in Renal Cell Carcinoma: Case-Based Insights | |||
| 12:04 - 12:07 | Case presentation | ||
| 12:08 - 12:15 | Open Approach | ||
| 12:16 - 12:23 | Robotic Approach | ||
| 12:24 - 12:30 | Systemic Treatment | ||
| 12:30 - 13:30 | Lunch Break |
||
| 13:30 - 14:00 | SESSION: Metastatic Renal Cancer Metastatic Renal Cancer with a Case Report |
||
| 13:30 - 13:34 | Case presentation | ||
| 13:35 - 13:42 | Urologist Perspective | ||
| 13:43 - 13:52 | Medical Oncologist Perspective | ||
| 13:53 - 14:00 | Radiation Oncologist Perspective | ||
| 14:00 - 15:00 | SESSION: Current Approaches in Testicular and Penile Tumors: Diagnosis and Treatment | ||
| 14:00 - 14:10 | Refining Biomarker Precision in Testis Cancer: Beyond AFP and b-hCG | ||
| 14:10 - 14:14 | Case presentation | ||
| 14:15 - 14:22 | Urologist Perspective | ||
| 14:23 - 14:30 | Medical Oncologist Perspective | ||
| 14:30 - 14:40 | Stage-Specific Strategies in the Systemic Management of Testicular Cancer | ||
| RPLND: Key Tips for Speedy Recovery | |||
| 14:40 - 14:50 | Open | ||
| 14:50 - 15:00 | Robotic | ||
| 15:00 - 15:10 | Key Insights and Challenges from the EAU–ASCO Penile Cancer Guidelines | ||
| 15:10 - 15:25 | Coffee Break |
||
| 15:25 - 16:00 | Satellite Symposium | ||
| 16:00 - 16:35 | SESSION: Artificial Intelligence-Powered Uro-oncology: From Precision Diagnosis to Personalized | ||
| 16:00 - 16:09 | Beyond Digital Transformation: Urological Approaches Reshaped by AI | ||
| 16:10 - 16:17 | Digital Anatomy of Prostate Cancer: New Horizons in Diagnosis and Treatment with AI | ||
| 16:18 - 16:26 | The Digital Journey of Bladder Cancer: New Approaches to Clinical Management with AI | ||
| 16:26 - 16:35 | Renal Oncology in the AI Era: Enhanced Diagnostics and Smarter Decision Making | ||
| 16:35 - 17:15 | Satellite Symposium | ||
| 17:15 - 17:45 | SESSION: Functional Urology Session Living with Cancer: Strategies for Genito-Urinary Function and Quality of Life |
||
| 17:15 - 17:25 | Erectile Function, Continence, and Quality of Life: Clinical Perspectives Post-RP | ||
| 17:25 - 17:35 | Post-RS Functional Outcomes: Erectile Function, Continence, and Quality of Life | ||
| 17:35 - 17:45 | Hormonal Health and Fertility in Testicular Cancer: A Guideline-Focused Framework for Quality of Life | ||
| HALL B | |||
| 08:30 - 10:00 | SESSION: BPH Surgery Masterclass Course | ||
| 08:30 - 08:40 | Energy Selection in Prostate Enucleation: Holmium | ||
| 08:40 - 08:50 | Energy Selection in Prostate Enucleation: Thulium | ||
| 08:50 - 09:00 | Complication Management in Laser Enucleation Surgery: Practical Approaches | ||
| 09:00 - 09:10 | Robotic Prostate Adenomectomy | ||
| 09:10 - 09:20 | Rezum | ||
| 09:20 - 09:30 | Prostate laser ablation | ||
| 09:30 - 09:45 | Expert Q&A Session: Closing Remarks and Final Assessment | ||
| 09:45 - 10:00 | Coffee Break |
||
| 10:15 - 11:15 | Balkan Countries Session | ||
| 11:15 - 12:30 | Oral Presentation Session 1 | ||
| 12:30 - 13:30 | Lunch Break |
||
| 13:30 - 14:45 | SESSION: AI-Based Approaches in Uro-Oncology: Spanning Diagnosis to Therapy | ||
| 13:30 - 13:40 | Next-Generation Diagnostic Integration with AI in Prostate Cancer | ||
| 13:40 - 13:50 | AI-Driven NeuroSAFE Prostatectomy: A New Era in Nerve-Sparing Surgery | ||
| 13:50 - 14:00 | Artificial Intelligence Integration in Bladder Cancer Diagnostics: Emerging Horizons | ||
| 14:00 - 14:10 | AI-Guided Prediction of BCG Response: A New Era in NMIBC Management | ||
| 14:10 - 14:20 | Next-Generation AI-Integrated Diagnostics in Renal Cancer | ||
| 14:20 - 14:30 | The AI Era in Robotic Urologic Surgery: Emerging Autonomous Techniques | ||
| 14:30 - 14:45 | Expert Q&A Session: Closing Remarks and Final Assessment | ||
| 14:45 - 15:00 | Coffee Break |
||
| 15:00 - 16:00 | Oral Presentation Session 2 | ||
| 16:00 - 16:15 | Coffee Break |
||
| 16:15 - 17:15 | SESSION: Incontinence and Reconstructive Urology | ||
| 17:15 - 18:00 | Oral Presentation Session 3 | ||
| HALL A | |||
| 08:30 - 10:00 | SESSION: Take home messages | ||
| 08:30 - 08:45 | Radiology | ||
| 08:45 - 09:00 | Pathology | ||
| 09:00 - 09:20 | Urology | ||
| 09:20 - 09:40 | Medical oncology | ||
| 09:40 - 10:00 | Radiation Oncology | ||
| 10:00 - 10:15 | Coffee Break |
||
| 10:15 - 11:00 | SESSION: Selected Top Abstracts: Cutting-Edge Research in Urology | ||
| 10:15 - 10:25 | 3rd Best Paper Presentation | ||
| 10:25 - 10:35 | 2nd Best Paper Presentation | ||
| 10:35 - 10:45 | 1st Best Paper Presentation | ||
| 10:45 - 11:00 | Announcement of the award winners for the papers | ||
| 11:00 - 12:00 | Closing Ceremony | ||